DBV Technologies | DBVT - Ingresos Por Ventas





Ventas Cambio Fecha
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amarin USD 49.22M 451K 2025-12
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
DBV Technologies USD 2.77M 1.31M 2025-09
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Halozyme Therapeutics USD 451.76M 97.76M 2025-12
Incyte USD 1.51B 140M 2025-12
Insmed USD 263.8M 121.8M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
PTC Therapeutics USD 164.7M 46.3M 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
United Therapeutics USD 790.2M 9.3M 2025-12